GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 395, 709–733 (2020).

Article  Google Scholar 

2023 USRDS annual data report: epidemiology of kidney disease in the United States. United States Renal Data System https://adr.usrds.org/2023 (2023).

Foreman, K. J. et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories. Lancet 392, 2052–2090 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Alfego, D. et al. Chronic kidney disease testing among at-risk adults in the U.S. remains low: real-world evidence from a national laboratory database. Diabetes Care 44, 2025–2032 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stempniewicz, N. et al. Chronic kidney disease testing among primary care patients with type 2 diabetes across 24 U.S. health care organizations. Diabetes Care 44, 2000–2009 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chu, C. D. et al. Estimated prevalence and testing for albuminuria in US adults at risk for chronic kidney disease. JAMA Netw. Open. 6, e2326230 (2023).

Article  PubMed  PubMed Central  Google Scholar 

Shin, J.-I. et al. Albuminuria testing in hypertension and diabetes: an individual-participant data meta-analysis in a global consortium. Hypertension 78, 1042–1052 (2021).

Article  CAS  PubMed  Google Scholar 

Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 105, S117–S314 (2024).

Article  Google Scholar 

Writing Group for the CKD Prognosis Consortium. Estimated glomerular filtration rate, albuminuria, and adverse outcomes: an individual-participant data meta-analysis. JAMA 330, 1266–1277 (2023).

Article  PubMed Central  Google Scholar 

Levey, A. S. et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int. 80, 17–28 (2011).

Article  PubMed  Google Scholar 

Potok, O. A. et al. Patients’, nephrologists,’ and predicted estimations of ESKD risk compared with 2-year incidence of ESKD. Clin. J. Am. Soc. Nephrol. 14, 206–212 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Grams Morgan, E. et al. Kidney-failure risk projection for the living kidney-donor candidate. N. Engl. J. Med. 374, 411–421 (2016).

Article  CAS  PubMed  Google Scholar 

National Institute for Health and Care Excellence (NICE). Chronic Kidney Disease: Assessment and Management (2021).

Tangri, N. et al. A predictive model for progression of chronic kidney disease to kidney failure. JAMA 305, 1553–1559 (2011).

Article  CAS  PubMed  Google Scholar 

Tangri, N. et al. Multinational assessment of accuracy of equations for predicting risk of kidney failure: a meta-analysis. JAMA 315, 164–174 (2016).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Grams, M. E. et al. Proteins associated with risk of kidney function decline in the general population. J. Am. Soc. Nephrol. 32, 2291–2302 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Naranjo, F. S. et al. Estimating kidney failure risk using electronic medical records. Kidney360 2, 415–424 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Grams, M. E. et al. The Kidney Failure Risk Equation: evaluation of novel input variables including eGFR estimated using the CKD-EPI 2021 equation in 59 cohorts. J. Am. Soc. Nephrol. 34, 482–494 (2023).

PubMed  PubMed Central  Google Scholar 

Neuen, B. L. et al. Timing of cardio-kidney protection with SGLT2 inhibitors: insights from four large-scale placebo-controlled outcome trials. Circulation 150, 343–345 (2024).

Article  PubMed  Google Scholar 

Levey, A. S. et al. GFR decline as an end point for clinical trials in CKD: a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration. Am. J. Kidney Dis. 64, 821–835 (2014).

Article  PubMed  Google Scholar 

Levey, A. S. et al. Change in albuminuria and GFR as end points for clinical trials in early stages of CKD: a scientific workshop sponsored by the National Kidney Foundation in collaboration with the US Food and Drug Administration and European Medicines Agency. Am. J. Kidney Dis. 75, 84–104 (2020).

Article  CAS  PubMed  Google Scholar 

Grams, M. E. et al. Development and validation of prediction models of adverse kidney outcomes in the population with and without diabetes. Diabetes Care 45, 2055–2063 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ndumele, C. E. et al. Cardiovascular–kidney–metabolic health: a presidential advisory from the American Heart Association. Circulation 148, 1606–1635 (2023).

Article  PubMed  Google Scholar 

Khan, S. S. et al. Development and validation of the American Heart Association’s PREVENT equations. Circulation 149, 430–449 (2024).

Article  PubMed  Google Scholar 

Hippisley-Cox, J., Coupland, C. & Brindle, P. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study. BMJ 357, j2099 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Grams, M. E. et al. Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate. Kidney Int. 93, 1442–1451 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Ramspek, C. L. et al. Kidney failure prediction models: a comprehensive external validation study in patients with advanced CKD. J. Am. Soc. Nephrol. 32, 1174–1186 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Ramspek, C. L., de Jong, Y., Dekker, F. W. & van Diepen, M. Towards the best kidney failure prediction tool: a systematic review and selection aid. Nephrol. Dial. Transplant. 35, 1527–1538 (2020).

Article  PubMed  Google Scholar 

Johnson, E. S., Thorp, M. L., Platt, R. W. & Smith, D. H. Predicting the risk of dialysis and transplant among patients with CKD: a retrospective cohort study. Am. J. Kidney Dis. 52, 653–660 (2008).

Article  PubMed  Google Scholar 

Schroeder, E. B. et al. Predicting 5-year risk of RRT in stage 3 or 4 CKD: development and external validation. Clin. J. Am. Soc. Nephrol. 12, 87–94 (2017).

Article  CAS  PubMed  Google Scholar 

Zacharias, H. U. et al. A predictive model for progression of CKD to kidney failure based on routine laboratory tests. Am. J. Kidney Dis. 79, 217–230.e1 (2022).

Article  CAS  PubMed  Google Scholar 

Ferguson, T. et al. Development and external validation of a machine learning model for progression of CKD. Kidney Int. Rep. 7, 1772–1781 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Tangri, N. et al. Machine learning for prediction of chronic kidney disease progression: validation of the Klinrisk model in the CANVAS Program and CREDENCE trial. Diabetes Obes. Metab. 26, 3371–3380 (2024).

Article  PubMed  Google Scholar 

Liu, P. et al. Predicting the risks of kidney failure and death in adults with moderate to severe chronic kidney disease: multinational, longitudinal, population based, cohort study. BMJ 385, e078063 (2024).

Article  PubMed  PubMed Central  Google Scholar 

Liu, H. et al. Epigenomic and transcriptomic analyses define core cell types, genes and targetable mechanisms f